EndocrinologyPeer Reviewed
Long-term recombinant human growth hormone therapy in Dent's disease type 1.
Authors (6)
Miao HuangDepartment of Endocrinology and Metabolism in Pediatrics, Shenzhen Maternity and Child Healthcare Hospital, Southern Medical University, Shenzhen, Guangdong Province, China. 961994600@qq.com.
Guoqing DongDepartment of Endocrinology and Metabolism in Pediatrics, Shenzhen Maternity and Child Healthcare Hospital, Southern Medical University, Shenzhen, Guangdong Province, China.
Yongmei ZengDepartment of Endocrinology and Metabolism in Pediatrics, Shenzhen Maternity and Child Healthcare Hospital, Southern Medical University, Shenzhen, Guangdong Province, China.
Fan WuShenzhen Institution of Transfusion Medicine, Shenzhen Blood Center, Shenzhen, Guangdong Province, China.
Endokrynologia Polska
Unknown
Published
Jan 01, 2025
Abstract
Not required for Clinical Vignette.
Keywords
CLCN5 mutationDent diseasechronic kidney diseasegrowth hormone therapygrowth retardation
Article Metrics
Sourcepubmed
Related Research
Explore more articles in this research category to discover related studies and findings.